title: A prospective, follow-along study of the course of social phobia: II. Testing for basic predictors of course.
abstract: This study examined the 65-week outcome of a group of subjects with social phobia to determine predictors of course. Social phobic patients in the Harvard/Brown Anxiety Disorders Research Project study were followed for 65 weeks using the Longitudinal Interval Follow-Up Evaluation-UpJohn scale. The following variables did not predict outcome over the course of the study: sex, age of onset, duration of illness, lifetime history of various anxiety disorders, current comorbidity of anxiety or depressive disorders, Global Assessment Scale score, or measures of role functioning. We find that in a social phobic population with a mean duration of illness of 18 years, none of the tested variables examined predicted 65-week outcome.
authors.affiliation: Department of Psychiatry, Harvard Medical School, Massachusetts, USA.
authors.forename: J
authors.initials: J
authors.lastname: Reich
authors.forename: I
authors.initials: I
authors.lastname: Goldenberg
authors.forename: R
authors.initials: R
authors.lastname: Goisman
authors.forename: R
authors.initials: R
authors.lastname: Vasile
authors.forename: M
authors.initials: M
authors.lastname: Keller
mesh_terms: D017668:Age of Onset; D001008:Anxiety Disorders / Q000453:epidemiology; D015897:Comorbidity; D003866:Depressive Disorder / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D017063:Outcome Assessment, Health Care; D010698:Phobic Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D011336:Probability; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012720:Severity of Illness Index; D012737:Sex Factors; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D011619:Psychotropic Drugs